LabGenomics (A084650) Stock Overview
Engages in the research and development of biotechnology products in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
A084650 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
LabGenomics Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩2,295.00 |
| 52 Week High | ₩3,915.00 |
| 52 Week Low | ₩1,991.00 |
| Beta | -0.28 |
| 1 Month Change | -4.18% |
| 3 Month Change | -3.77% |
| 1 Year Change | -32.80% |
| 3 Year Change | -32.80% |
| 5 Year Change | -49.56% |
| Change since IPO | 93.26% |
Recent News & Updates
LabGenomics Co., Ltd.'s (KOSDAQ:084650) Price Is Right But Growth Is Lacking
Oct 28
Insufficient Growth At LabGenomics Co., Ltd. (KOSDAQ:084650) Hampers Share Price
May 19Is LabGenomics (KOSDAQ:084650) Using Debt In A Risky Way?
Apr 08Recent updates
LabGenomics Co., Ltd.'s (KOSDAQ:084650) Price Is Right But Growth Is Lacking
Oct 28Insufficient Growth At LabGenomics Co., Ltd. (KOSDAQ:084650) Hampers Share Price
May 19Is LabGenomics (KOSDAQ:084650) Using Debt In A Risky Way?
Apr 08There's No Escaping LabGenomics Co., Ltd.'s (KOSDAQ:084650) Muted Revenues Despite A 46% Share Price Rise
Jan 06Not Many Are Piling Into LabGenomics Co., Ltd. (KOSDAQ:084650) Stock Yet As It Plummets 26%
Nov 17Is LabGenomics (KOSDAQ:084650) Weighed On By Its Debt Load?
Nov 08Slammed 29% LabGenomics Co., Ltd. (KOSDAQ:084650) Screens Well Here But There Might Be A Catch
Sep 21Market Might Still Lack Some Conviction On LabGenomics Co., Ltd. (KOSDAQ:084650) Even After 35% Share Price Boost
Aug 06Is LabGenomics (KOSDAQ:084650) Using Too Much Debt?
Jul 27Market Still Lacking Some Conviction On LabGenomics Co., Ltd. (KOSDAQ:084650)
Apr 09If You Like EPS Growth Then Check Out LabGenomics (KOSDAQ:084650) Before It's Too Late
Mar 31Shareholder Returns
| A084650 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | -8.4% | 2.3% | 4.1% |
| 1Y | -32.8% | 22.8% | 57.7% |
Return vs Industry: A084650 underperformed the KR Biotechs industry which returned 22.8% over the past year.
Return vs Market: A084650 underperformed the KR Market which returned 57.7% over the past year.
Price Volatility
| A084650 volatility | |
|---|---|
| A084650 Average Weekly Movement | 5.0% |
| Biotechs Industry Average Movement | 7.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in KR Market | 10.5% |
| 10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A084650 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A084650's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 143 | Sung Chin | www.labgenomics.co.kr |
LabGenomics Co., Ltd. engages in the research and development of biotechnology products in South Korea. It is also involved in the sale of diagnostic devices. The company was founded in 2002 and is based in Seongnam-si, South Korea.
LabGenomics Co., Ltd. Fundamentals Summary
| A084650 fundamental statistics | |
|---|---|
| Market cap | ₩162.96b |
| Earnings (TTM) | -₩35.04b |
| Revenue (TTM) | ₩87.97b |
Is A084650 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A084650 income statement (TTM) | |
|---|---|
| Revenue | ₩87.97b |
| Cost of Revenue | ₩57.21b |
| Gross Profit | ₩30.76b |
| Other Expenses | ₩65.80b |
| Earnings | -₩35.04b |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -471.99 |
| Gross Margin | 34.97% |
| Net Profit Margin | -39.83% |
| Debt/Equity Ratio | 24.5% |
How did A084650 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/04 11:51 |
| End of Day Share Price | 2025/11/04 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
LabGenomics Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hyung Soo Kim | Hanwha Investment & Securities Co., Ltd. |
| Wan Ku | iM Securities |
| Kyung-Churl Noh | SK Securities Co., Ltd. |